889 related articles for article (PubMed ID: 27321932)
1. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice.
Motiño O; Agra N; Brea Contreras R; Domínguez-Moreno M; García-Monzón C; Vargas-Castrillón J; Carnovale CE; Boscá L; Casado M; Mayoral R; Valdecantos MP; Valverde ÁM; Francés DE; Martín-Sanz P
Biochim Biophys Acta; 2016 Sep; 1862(9):1710-23. PubMed ID: 27321932
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte-specific clusterin overexpression attenuates diet-induced nonalcoholic steatohepatitis.
Park JS; Shim YJ; Kang BH; Lee WK; Min BH
Biochem Biophys Res Commun; 2018 Jan; 495(2):1775-1781. PubMed ID: 29229391
[TBL] [Abstract][Full Text] [Related]
4. Caspase 3 inactivation protects against hepatic cell death and ameliorates fibrogenesis in a diet-induced NASH model.
Thapaliya S; Wree A; Povero D; Inzaugarat ME; Berk M; Dixon L; Papouchado BG; Feldstein AE
Dig Dis Sci; 2014 Jun; 59(6):1197-206. PubMed ID: 24795036
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Ding Y; Sun X; Chen Y; Deng Y; Qian K
Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
[TBL] [Abstract][Full Text] [Related]
6. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
[TBL] [Abstract][Full Text] [Related]
7. Lipid metabolism, oxidative stress and cell death are regulated by PKC delta in a dietary model of nonalcoholic steatohepatitis.
Greene MW; Burrington CM; Lynch DT; Davenport SK; Johnson AK; Horsman MJ; Chowdhry S; Zhang J; Sparks JD; Tirrell PC
PLoS One; 2014; 9(1):e85848. PubMed ID: 24454937
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte-specific deletion of Brg1 alleviates methionine-and-choline-deficient diet (MCD) induced non-alcoholic steatohepatitis in mice.
Kong M; Chen X; Xu H; Wenping ; Fang M; Xu Y
Biochem Biophys Res Commun; 2018 Sep; 503(1):344-351. PubMed ID: 29890136
[TBL] [Abstract][Full Text] [Related]
9. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.
Najt CP; Senthivinayagam S; Aljazi MB; Fader KA; Olenic SD; Brock JR; Lydic TA; Jones AD; Atshaves BP
Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G726-38. PubMed ID: 26968211
[TBL] [Abstract][Full Text] [Related]
10. Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis.
Jung YA; Choi YK; Jung GS; Seo HY; Kim HS; Jang BK; Kim JG; Lee IK; Kim MK; Park KG
Diabetes Res Clin Pract; 2014 Jul; 105(1):47-57. PubMed ID: 24842243
[TBL] [Abstract][Full Text] [Related]
11. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis.
Sugino H; Kumagai N; Watanabe S; Toda K; Takeuchi O; Tsunematsu S; Morinaga S; Tsuchimoto K
J Gastroenterol Hepatol; 2008 Dec; 23(12):1909-16. PubMed ID: 18422963
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
[TBL] [Abstract][Full Text] [Related]
13. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
[TBL] [Abstract][Full Text] [Related]
14. CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy.
Zhang X; Han J; Man K; Li X; Du J; Chu ES; Go MY; Sung JJ; Yu J
J Hepatol; 2016 Jan; 64(1):160-70. PubMed ID: 26394162
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice.
Kroy DC; Schumacher F; Ramadori P; Hatting M; Bergheim I; Gassler N; Boekschoten MV; Müller M; Streetz KL; Trautwein C
J Hepatol; 2014 Oct; 61(4):883-90. PubMed ID: 24845607
[TBL] [Abstract][Full Text] [Related]
16. β
Drescher HK; Schippers A; Clahsen T; Sahin H; Noels H; Hornef M; Wagner N; Trautwein C; Streetz KL; Kroy DC
J Hepatol; 2017 Jun; 66(6):1251-1264. PubMed ID: 28192190
[TBL] [Abstract][Full Text] [Related]
17. Suppressing cyclooxygenase-2 prevents nonalcoholic and inhibits apoptosis of hepatocytes that are involved in the Akt/p53 signal pathway.
Wu J; Chen C; Hu X; Cai X; Guan Y; Hu H; Wang Q; Chen X; Cai B; Jing X
Biochem Biophys Res Commun; 2016 Jan; 469(4):1034-40. PubMed ID: 26723251
[TBL] [Abstract][Full Text] [Related]
18. Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency.
Kim M; Yoo G; Randy A; Kim HS; Nho CW
Mol Nutr Food Res; 2017 May; 61(5):. PubMed ID: 27981809
[TBL] [Abstract][Full Text] [Related]
19. C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis.
Bae CR; Hino J; Hosoda H; Miyazato M; Kangawa K
Life Sci; 2018 Sep; 209():349-356. PubMed ID: 30114411
[TBL] [Abstract][Full Text] [Related]
20. Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor.
Aljobaily N; Krutsinger K; Viereckl MJ; Joly R; Menlove B; Cone B; Suppes A; Han Y
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]